Albemarle Corp (ALB)
Official siteBASIC MATERIALS • SPECIALTY CHEMICALS • NYSE
Market Cap: $11.04B
Last updated: Nov 17, 2026 at 11:05 AM ET
Albemarle Corp (ALB) Financials: Revenue, Profit and Cash Flow
Albemarle reported revenue of $5.14B for the fiscal year ended Dec 31, 2025, down 4.4% from the year before. That year, net income was -$465.21M with a net margin of -9.0%, operating cash flow was $1.28B and free cash flow was $692.47M. The quarter ended Sep 30, 2026 had revenue of $1.55B and net income of $316.67M.
Revenue and Margins
The operating margin was -7.1% in the fiscal year ended Dec 2025. Over the 9 years to Dec 2025, revenue grew from $2.68B, a compound annual rate of 7.5%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $5.14B | -4.4% | 13.0% | -7.1% | -9.0% |
| Dec 2024 | $5.38B | -44.1% | 1.2% | -33.0% | -21.1% |
| Dec 2023 | $9.62B | +31.4% | 12.3% | 2.6% | 17.4% |
| Dec 2022 | $7.32B | +120.0% | 42.0% | 33.7% | 38.5% |
| Dec 2021 | $3.33B | +6.4% | 30.0% | 24.0% | 6.0% |
| Dec 2020 | $3.13B | -12.8% | 31.8% | 16.2% | 14.3% |
| Dec 2019 | $3.59B | +6.4% | 35.0% | 18.6% | 16.8% |
| Dec 2018 | $3.37B | +9.9% | 36.1% | 20.8% | 21.9% |
| Dec 2017 | $3.07B | +14.7% | 36.0% | 18.6% | 3.2% |
| Dec 2016 | $2.68B | N/A | 36.2% | 17.9% | 25.4% |
Income Statement
In the fiscal year ended Dec 2025, the net loss narrowed from the year before. In the quarter ended Sep 2026, net income turned positive after a loss in the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5.14B | $5.38B | $9.62B | $7.32B | $3.33B | $3.13B | $3.59B | $3.37B | $3.07B | $2.68B |
| Cost of revenue | $4.47B | $5.31B | $8.43B | $4.25B | $2.33B | $2.13B | $2.33B | $2.16B | $1.97B | $1.71B |
| Gross profit | $668.72M | $62.54M | $1.19B | $3.07B | $997.97M | $994.85M | $1.26B | $1.22B | $1.11B | $970.31M |
| Research and development | $51.40M | $86.72M | $85.72M | $71.98M | $54.03M | $59.21M | $58.29M | $70.05M | $84.33M | $80.47M |
| Operating income | -$367.08M | -$1.78B | $251.88M | $2.47B | $798.43M | $505.81M | $666.12M | $701.11M | $571.66M | $478.68M |
| Net income | -$465.21M | -$1.14B | $1.67B | $2.82B | $199.94M | $446.62M | $604.36M | $739.14M | $99.47M | $680.77M |
| EBITDA | $314.26M | -$1.01B | $863.94M | $2.85B | N/A | $678.62M | $834.13M | $1.05B | $759.08M | $806.61M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.55B | $1.74B | $1.43B | $1.43B | $1.31B | $1.33B | $1.08B | $1.23B | $1.35B | $1.43B | $1.36B | $2.36B |
| Gross profit | $300.72M | $590.30M | $500.97M | $197.93M | $117.61M | $196.88M | $156.30M | $138.21M | -$104.03M | -$10.58M | $38.94M | -$704.05M |
| Operating income | $148.16M | $452.94M | $233.51M | -$217.39M | -$216.99M | $47.53M | $19.76M | $4.40M | -$1.11B | -$492.61M | -$179.51M | -$849.87M |
| Net income | $316.67M | $499.21M | $328.98M | -$401.76M | -$147.94M | $35.19M | $49.30M | $85.11M | -$1.06B | -$176.59M | $16.65M | -$603.29M |
Balance Sheet
As of Dec 2025, total debt of $3.19B exceeded cash and equivalents by $1.58B.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $16.37B | $16.61B | $18.27B | $15.46B | $10.97B | $10.45B | $9.86B | $7.58B | $7.75B | $8.16B |
| Current assets | $4.01B | $3.84B | $5.22B | $5.19B | $1.99B | $2.21B | $2.23B | $2.00B | $2.48B | $3.31B |
| Cash and equivalents | $1.62B | $1.19B | $889.90M | $1.50B | $439.27M | $746.72M | $613.11M | $555.32M | $1.14B | $2.27B |
| Total liabilities | $6.59B | $6.41B | $8.61B | $7.27B | $5.17B | $5.98B | $5.77B | $3.82B | $3.93B | $4.22B |
| Short-term debt | $74.08M | $398.02M | $625.76M | $2.13M | $389.92M | $804.68M | $187.34M | $307.29M | $422.01M | $247.54M |
| Long-term debt | $3.12B | $3.12B | $3.54B | $3.21B | $2.00B | $2.77B | $2.86B | $1.40B | $1.42B | $2.12B |
| Shareholder equity | $9.53B | $9.96B | $9.41B | $7.98B | $5.63B | $4.27B | $3.93B | $3.59B | $3.67B | $3.80B |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $16.08B | $15.91B | $15.14B | $16.37B | $17.15B | $17.29B | $17.00B | $16.61B | $17.46B | $18.39B | $19.03B | $18.27B |
| Total liabilities | $5.26B | $5.37B | $5.03B | $6.59B | $6.88B | $6.79B | $6.72B | $6.41B | $6.96B | $6.91B | $7.23B | $8.61B |
| Cash and equivalents | $1.85B | $1.63B | $1.09B | $1.62B | $1.93B | $1.81B | $1.52B | $1.19B | $1.66B | $1.83B | $2.06B | $889.90M |
| Shareholder equity | $10.54B | $10.28B | $9.85B | $9.53B | $10.00B | $10.24B | $10.03B | $9.96B | $10.24B | $11.22B | $11.53B | $9.41B |
Cash Flow
In the fiscal year ended Dec 2025, free cash flow was 54.1% of operating cash flow. Dividends came to 54.2% of it.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $1.28B | $687.88M | $1.33B | $1.91B | $344.26M | $798.91M | $719.37M | $546.16M | $303.98M | $735.52M |
| Capital expenditures | $589.80M | $1.68B | $2.15B | $1.26B | $953.67M | $850.48M | $851.80M | $699.99M | $317.70M | $196.65M |
| Free cash flow | $692.47M | -$992.65M | -$827.96M | $646.20M | -$609.41M | -$51.56M | -$132.42M | -$153.83M | -$13.72M | $538.87M |
| Dividends paid | $375.45M | $348.47M | $292.82M | $228.64M | $273.99M | $193.88M | $235.39M | $159.35M | $177.31M | $171.21M |
| Share repurchases | N/A | N/A | N/A | N/A | N/A | N/A | $0 | $500.00M | $250.00M | $0 |
| Investing cash flow | -$146.01M | -$1.58B | -$2.56B | -$1.42B | -$666.59M | -$863.57M | -$1.66B | -$303.69M | -$357.80M | $2.92B |
| Financing cash flow | -$834.19M | $1.24B | $623.91M | $611.89M | $50.21M | $177.26M | $1.04B | -$786.53M | -$1.09B | -$1.58B |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $405.80M | $710.00M | $346.24M | $388.49M | $355.60M | -$9.03M | $547.21M | -$4.38M | $227.11M | $367.19M | $97.95M | -$96.96M |
| Capital expenditures | $80.37M | $71.73M | $98.68M | $155.38M | $132.16M | $119.63M | $182.62M | $342.81M | $303.13M | $455.27M | $579.32M | $689.35M |
| Free cash flow | $325.42M | $638.27M | $247.57M | $233.10M | $223.44M | -$128.66M | $364.58M | -$347.19M | -$76.02M | -$88.08M | -$481.37M | -$786.31M |
Frequently Asked Questions About ALB
What is Albemarle's annual revenue?
Albemarle reported revenue of $5.14B for the fiscal year ended Dec 31, 2025.
How fast is Albemarle's revenue growing?
Revenue was down 4.4% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was -11.1%.
Is Albemarle profitable?
No. Albemarle reported net income of -$465.21M for the fiscal year ended Dec 31, 2025, with a net margin of -9.0%.
How much free cash flow does ALB generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of $1.28B minus capital expenditures of $589.80M produced free cash flow of $692.47M.
How much debt does Albemarle have?
The balance sheet dated Dec 31, 2025 reported long-term debt of $3.12B, short-term debt of $74.08M and cash and equivalents of $1.62B.
ALB pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts